“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money
In Brief: Boson Hotel Offers Free Rooms to Cancer Patients; Smoking Program Report Available
DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial
Concepts Approved For $26.5Million In DCPC contracts, Including Heavy Smoker Program
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer









